Is drug price policy evidence-based or evidence-deficient?
The federal government’s failed attempt to impose excessive price regulations on patented medicines reveals the information deficit in pharmaceutical policy.

The Liberal Party’s 2015 federal election platform promised that its health policy decisions would be evidence based. But recent amendments to Canada’s patented medicines regulations show that the government's price control policies are based on faulty evidence and unproven assumptions, which ...
SPONSORED CONTENT
Get Weekend Point of View Newsletter
A round up of the past week’s opinion writers and columnists on Saturdays and Sundays.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy












